|
Volumn 17, Issue 10, 2005, Pages 534-538
|
A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial.
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
DRUG DERIVATIVE;
FIBRINOGEN RECEPTOR;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
TICLOPIDINE;
ANGIOCARDIOGRAPHY;
ARTICLE;
BLOOD CLOTTING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DOUBLE BLIND PROCEDURE;
DRUG ANTAGONISM;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
METHODOLOGY;
MIDDLE AGED;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RESTENOSIS;
STENT;
ANTIBODIES, MONOCLONAL;
ASPIRIN;
BLOOD COAGULATION;
CORONARY ANGIOGRAPHY;
CORONARY DISEASE;
CORONARY RESTENOSIS;
DIABETES MELLITUS, TYPE 2;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MALE;
MIDDLE AGED;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
PROSPECTIVE STUDIES;
STENTS;
TICLOPIDINE;
|
EID: 33748107700
PISSN: None
EISSN: 15572501
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|